Skip to main content

Animations

MJFF Publications

3791 - 3800 of 6568 Results
Title
Year
  • Year
  • 2010
  • 2025
  • 2015
  • 2016
  • 2021
  • 2021
  • 2021
  • 2021
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.07.010
    Citation Count: 279
  • Summary Details
    OPEN
    Title: Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adn1927
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Sustained attention training reduces spatial bias in Parkinson’s disease: a pilot case series
    Journal Name: Neurocase
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/13554794.2015.1088035
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population‐based elderly cohort
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2016.06.001
    Citation Count: 154
  • Summary Details
    OPEN
    Title: A 2-Pyridone Amide Inhibitor of Transcriptional Activity in Chlamydia trachomatis
    Journal Name: Antimicrobial Agents and Chemotherapy
    Publisher: American Society for Microbiology
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1128/aac.01826-20
    Citation Count: 7
  • Summary Details
    OPEN
    Title: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brain
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2021.128164
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Responsive Versus Continuous Deep Brain Stimulation for Speech in Essential Tremor: A Pilot Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29865
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Long‐Read Sequencing Unravels the Complexity of Structural Variants in PRKN in Two Individuals with Early‐Onset Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29914
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.